%0 Journal Article
%A Maerevoet, Marie
%A Zijlstra, Josee M
%A Follows, George
%A Casasnovas, Rene-Olivier
%A Vermaat, J S P
%A Kalakonda, Nagesh
%A Goy, Andre
%A Choquet, Sylvain
%A Van Den Neste, Eric
%A Hill, Brian
%A Thieblemont, Catherine
%A Cavallo, Federica
%A De la Cruz, Fatima
%A Kuruvilla, John
%A Hamad, Nada
%A Jaeger, Ulrich
%A Caimi, Paolo
%A Gurion, Ronit
%A Warzocha, Krzysztof
%A Bakhshi, Sameer
%A Sancho, Juan-Manuel
%A Schuster, Michael
%A Egyed, Miklos
%A Offner, Fritz
%A Vassilakopoulos, Theodoros P
%A Samal, Priyanka
%A Ku, Matthew
%A Ma, Xiwen
%A Corona, Kelly
%A Chamoun, Kamal
%A Shah, Jatin
%A Shacham, Sharon
%A Kauffman, Michael G
%A Canales, Miguel
%T Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.
%D 2021
%U http://hdl.handle.net/10668/18206
%X Patients with RR DLBCL who have received ≥ 2 lines of therapy have limited treatment options and an expected overall survival (OS) of 
%K DLBCL
%K Exportin-1
%K SINE compounds
%K Selinexor
%~